Literature DB >> 32310136

Additional clinical value of voxel-based morphometric MRI post-processing for MRI-negative epilepsies: a prospective study.

Riëm El Tahry1, Susana Ferrao Santos1, Pascal Vrielynck2, Marianne de Tourtchaninoff1, Thierry Duprez3, Geraldo Ribeiro Vaz4, Christian Raftopoulos4, Joon Yul Choi5, Zhong Irene Wang5.   

Abstract

Magnetic resonance imaging is of paramount importance in the presurgical evaluation of drug resistant epilepsy. Detection of a potentially epileptogenic lesion significantly improves seizure outcome after surgery. To optimize the detection of subtle lesions, MRI post-processing techniques may be of essential help. In this study, we aimed to evaluate the detection rate of the voxel-based morphometric analysis program (MAP) in a prospective trial. We aimed to study the MAP+ findings in terms of their clinical value in the decision-making process of the presurgical evaluation. We included, prospectively, 21 patients who had negative MRI by visual analysis. In a first step, results of the conventional non-invasive presurgical evaluation were discussed, blinded to the MAP results, in multidisciplinary patient management conferences to determine the possible seizure onset zone and to set surgical or invasive evaluation plans. Thereafter, MAP results were presented, and the change of initial clinical plan was recorded. All MAP detections were reaffirmed by a neuroradiologist with epilepsy expertise. For the 21 patients included, mean age at the time of patient management conference was 26 years (SD 15 +/- years, range: 5-54 years). In total, 4/21 had temporal lobe epilepsy and 17/21 had extra-temporal lobe epilepsy. MAP was positive in 10/21 (47%) patients and in 6/10 (60%) a diagnosis of focal cortical dysplasia was confirmed after neuroradiologist review, corresponding to a 28% detection rate. MAP+ findings had a clear impact on the initial management in 7/10 patients (7/21, 33% of all patients), which included an adaptation of the intracranial EEG plan (6/7 patients), or the decision to proceed directly to surgery (1/7 patients). MRI post-processing using the MAP method yielded an increased detection rate of 28% for subtle dysplastic lesions in a prospective cohort of MRI-negative patients, indicating its potential value in epilepsy presurgical evaluation.

Entities:  

Keywords:  epilepsy surgery; morphometric analysis program; non-lesional MRI; pre-surgical evaluation; refractory epilepsy; voxel-based morphometry

Mesh:

Year:  2020        PMID: 32310136     DOI: 10.1684/epd.2020.1152

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  5 in total

1.  Value of 7T MRI and post-processing in patients with nonlesional 3T MRI undergoing epilepsy presurgical evaluation.

Authors:  Irene Wang; Sehong Oh; Ingmar Blümcke; Roland Coras; Balu Krishnan; Sanghoon Kim; Aaron McBride; Olesya Grinenko; Yicong Lin; Margit Overmyer; Tin Tun Aung; Mark Lowe; Mykol Larvie; Andreas V Alexopoulos; William Bingaman; Jorge A Gonzalez-Martinez; Imad Najm; Stephen E Jones
Journal:  Epilepsia       Date:  2020-09-19       Impact factor: 5.864

2.  Automatic Detection of Focal Cortical Dysplasia Type II in MRI: Is the Application of Surface-Based Morphometry and Machine Learning Promising?

Authors:  Zohreh Ganji; Mohsen Aghaee Hakak; Seyed Amir Zamanpour; Hoda Zare
Journal:  Front Hum Neurosci       Date:  2021-02-19       Impact factor: 3.169

Review 3.  MRI of focal cortical dysplasia.

Authors:  Horst Urbach; Elias Kellner; Nico Kremers; Ingmar Blümcke; Theo Demerath
Journal:  Neuroradiology       Date:  2021-11-27       Impact factor: 2.804

4.  Artificial Intelligence Applications in the Imaging of Epilepsy and Its Comorbidities: Present and Future.

Authors:  Fernando Cendes; Carrie R McDonald
Journal:  Epilepsy Curr       Date:  2022-01-12       Impact factor: 7.500

5.  "Within a minute" detection of focal cortical dysplasia.

Authors:  Horst Urbach; Marcel Heers; Dirk-Matthias Altenmueller; Andreas Schulze-Bonhage; Anke Maren Staack; Thomas Bast; Marco Reisert; Ralf Schwarzwald; Christoph P Kaller; Hans-Juergen Huppertz; Theo Demerath
Journal:  Neuroradiology       Date:  2021-10-09       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.